ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Ritter Pharmaceuticals Inc

Ritter Pharmaceuticals Inc (RTTR)

0,448
0,00
( 0,00% )
Mis à jour : 01:00:00

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,448
Prix Achat
0,4471
Prix Vente
0,45
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
0,448
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
5 181 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,17
Bénéfice par action (BPA)
-2,59
Chiffre d'affairess
-
Bénéfice net
-13,42M

À propos de Ritter Pharmaceuticals Inc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-

RTTR Dernières nouvelles

Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger...

Ritter Pharmaceuticals, Inc. Announces Stockholder Approval of Proposals Required for Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), announced today that, based upon the final vote...

Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special Meeting

LOS ANGELES, May 14, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter” or the “Company”), today announced that it has adjourned its special meeting of stockholders...

Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing

LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice from...

Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each o...

LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services...

Ritter Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2020

LOS ANGELES, May 01, 2020 (GLOBE NEWSWIRE) -- Form S-4 Declared Effective by the SEC and Ritter/Qualigen Merger Voting is Underway Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter...

Ritter Pharmaceuticals, Inc. Urges Stockholders to Vote Now on Proposed Merger with Biotech Company, Qualigen Inc.

The merger CANNOT be consummated without the approval of EACH of the proposals being voted on at the Special Meeting, including approval of a reverse stock split. LOS ANGELES, April 28, 2020...

Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC

Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders to Vote on Proposed Merger Scheduled for May 14, 2020 LOS ANGELES , April 16, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc...

Ritter Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019

Definitive merger agreement with Qualigen, Inc. announced in January 2020 LOS ANGELES, March 31, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”...

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigen’s Cancer and Infectious Disease Therapeutic Development Programs LOS ANGELES, Jan. 21, 2020 (GLOBE...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TRVITrevi Therapeutics Inc
US$ 4,2599
(71,08%)
50,11M
GOEVCanoo Inc
US$ 0,1996
(53,54%)
821,91M
PALIPalisade Bio Inc
US$ 2,14
(52,86%)
59,1M
LAESSEALSQ Corporation
US$ 1,7362
(50,97%)
196,36M
LNKSLinkers Industries Ltd
US$ 5,9563
(40,15%)
543,41k
SPGCSacks Parente Golf Inc
US$ 0,3699
(-73,58%)
24,29M
KROSKeros Therapeutics Inc
US$ 18,1412
(-73,57%)
11,06M
SFHGSamfine Creation Holdings Group Ltd
US$ 1,28
(-58,03%)
5,52M
TFFPTFF Pharmaceuticals Inc
US$ 0,0765
(-52,98%)
3,5M
BCTXBriaCell Therapeutics Corporation
US$ 0,6589
(-40,10%)
6,19M
GOEVCanoo Inc
US$ 0,20
(53,85%)
821,38M
LAESSEALSQ Corporation
US$ 1,735
(50,87%)
190,23M
CDTConduit Pharmaceuticals Inc
US$ 0,07995
(-9,46%)
104,27M
RGTIRigetti Computing Inc
US$ 6,9994
(-5,16%)
102,05M
NVDANVIDIA Corporation
US$ 137,92
(-1,00%)
86,77M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock